ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 935,03
-1,52%
Dow Jones
38 511,54
-0,88%
DAX
18 473,29
-1,13%
Brent Oil
83,415
-1,08%
Bitcoin
67 450,12
-1,23%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Profound Medical Corporation (PROF)

  7. Profound Medical Corporation (PROF) Actualités

PROF

Profound Medical (PROF)

Profound Medical Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PROF
DateHeureSourceTitreSymboleSociété
15/05/202423h00GlobeNewswire Inc.Profound Medical Annual General Meeting of Shareholders Voting ResultsNASDAQ:PROFProfound Medical Corporation
15/05/202422h12PR Newswire (Canada)PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTSNASDAQ:PROFProfound Medical Corporation
14/05/202415h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PROFProfound Medical Corporation
14/05/202413h30GlobeNewswire Inc.Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment PlanNASDAQ:PROFProfound Medical Corporation
09/05/202422h05GlobeNewswire Inc.Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue GuidanceNASDAQ:PROFProfound Medical Corporation
06/05/202422h15GlobeNewswire Inc.Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease SpectrumNASDAQ:PROFProfound Medical Corporation
22/04/202422h15GlobeNewswire Inc.Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
09/04/202413h45GlobeNewswire Inc.Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:PROFProfound Medical Corporation
07/03/202422h05GlobeNewswire Inc.Profound Medical Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
04/03/202422h30GlobeNewswire Inc.Profound Medical to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
27/02/202413h45GlobeNewswire Inc.Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA ProcedureNASDAQ:PROFProfound Medical Corporation
15/02/202422h30GlobeNewswire Inc.Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
16/01/202422h30GlobeNewswire Inc.Profound Medical Announces Non-Brokered Private PlacementNASDAQ:PROFProfound Medical Corporation
03/01/202422h15GlobeNewswire Inc.Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 RevenuesNASDAQ:PROFProfound Medical Corporation
28/12/202304h40GlobeNewswire Inc.Profound Medical Announces Pricing of US$20 Million Public Offering of Common SharesNASDAQ:PROFProfound Medical Corporation
27/12/202322h15GlobeNewswire Inc.Profound Medical Announces Proposed Public Offering of Common SharesNASDAQ:PROFProfound Medical Corporation
08/11/202313h45GlobeNewswire Inc.Profound Medical to Participate in the Stifel 2023 Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
03/11/202313h00GlobeNewswire Inc.Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC SettingNASDAQ:PROFProfound Medical Corporation
02/11/202321h05GlobeNewswire Inc.Profound Medical Announces Third Quarter 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
19/10/202322h30GlobeNewswire Inc.Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
10/10/202322h30GlobeNewswire Inc.Profound Medical 2023 Virtual Analyst & Investor Day AgendaNASDAQ:PROFProfound Medical Corporation
25/09/202322h05GlobeNewswire Inc.Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal BoostNASDAQ:PROFProfound Medical Corporation
21/09/202314h00GlobeNewswire Inc.Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13NASDAQ:PROFProfound Medical Corporation
19/09/202322h45GlobeNewswire Inc.Profound Medical to Participate in the 2023 Cantor Global Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
07/09/202301h23GlobeNewswire Inc.Profound Medical Announces At-the-Market Offering of up to US$30,000,000NASDAQ:PROFProfound Medical Corporation
09/08/202322h05GlobeNewswire Inc.Profound Medical Announces Second Quarter 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
02/08/202322h30GlobeNewswire Inc.Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
02/06/202319h40GlobeNewswire Inc.Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate DiseasesNASDAQ:PROFProfound Medical Corporation
30/05/202314h00GlobeNewswire Inc.Profound Medical Announces Upcoming Investor EventsNASDAQ:PROFProfound Medical Corporation
18/05/202314h00GlobeNewswire Inc.Profound Medical to Participate in A.G.P.’s Virtual Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
 Showing the most relevant articles for your search:NASDAQ:PROF

Dernières Valeurs Consultées

TG
BRYN
Berkshire Hathaway
COIN
PICAAGBP
PicaArtMoney
LSE
TPVD
Triple Point Income Vct
BOV
E1WL34R
Edwards Lifesciences
COIN
NUAUST
Neulaut
BIT
P128E6
BNP PARIBAS ISSUANCE
LSE
19YL
Investec Bnk 26
TG
0B2
Bawag
USOTC
EMKAF
EM Systems (GM)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés